Development of an immunofluorescence assay for detection of SARS-CoV-2

SARS-CoV-2, the etiologic agent of the COVID-19 pandemic, emerged as the cause of a global crisis in 2019. Currently, the main method for identification of SARS-CoV-2 is a reverse transcription (RT)-PCR assay designed to detect viral RNA in oropharyngeal (OP) or nasopharyngeal (NP) samples. While th...

Descripción completa

Detalles Bibliográficos
Autores principales: Atiya-Nasagi, Yafit, Milrot, Elad, Makdasi, Efi, Schuster, Ofir, Shmaya, Shlomo, Simon, Irit, Ben-Shmuel, Amir, Beth-Din, Adi, Weiss, Shay, Laskar, Orly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862410/
https://www.ncbi.nlm.nih.gov/pubmed/35192015
http://dx.doi.org/10.1007/s00705-022-05392-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862410/
https://www.ncbi.nlm.nih.gov/pubmed/35192015
http://dx.doi.org/10.1007/s00705-022-05392-z

Ejemplares similares